Concentrix (NASDAQ:CNXC – Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 11.180-11.770 for the period, compared to the consensus estimate of 11.970. The company issued revenue guidance of $9.5 billion-$9.6 billion, compared to the consensus revenue estimate of $9.7 billion. Concentrix also updated its FY25 guidance to $11.18-11.77 EPS.
Concentrix Trading Up 2.1 %
Shares of Concentrix stock opened at $47.47 on Thursday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a market capitalization of $3.08 billion, a P/E ratio of 15.41, a P/E/G ratio of 0.60 and a beta of 0.63. Concentrix has a 52-week low of $36.28 and a 52-week high of $106.10. The stock’s 50-day simple moving average is $43.25 and its 200 day simple moving average is $55.04.
Concentrix (NASDAQ:CNXC – Get Free Report) last posted its quarterly earnings results on Wednesday, January 15th. The company reported $3.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.01 by $0.25. The company had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.44 billion. Concentrix had a net margin of 2.18% and a return on equity of 16.57%. The company’s quarterly revenue was up 9.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $3.36 earnings per share. As a group, research analysts anticipate that Concentrix will post 10.11 EPS for the current year.
Wall Street Analyst Weigh In
Check Out Our Latest Stock Report on Concentrix
About Concentrix
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Featured Articles
- Five stocks we like better than Concentrix
- Most active stocks: Dollar volume vs share volume
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- What is Forex and How Does it Work?
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- Trading Stocks: RSI and Why it’s Useful
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.